Discover what makes Paris's biotech ecosystem so successful, as it just so happens to be one of the largest biotech clusters ...

Find out about the University of Edinburgh's work to convert our common plastic wast into the wildly used paracetamol.

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

In October last year, Judo Bio launched with $100 million in initial financing to develop oligonucleotide therapies delivered to the kidney, which has historically been a challenging organ to access ...

Having just enough of a fatty substance (lipid) called cholesterol in your body is important for bodily functions, but having too much of it, known as high cholesterol, can increase your risk of ...

Immunotherapies in high demand; fueling R&D. The immunotherapy market size was valued at $226.38 billion last year, and it is only projected to grow by almost 12% by 2030, according to Grand View ...

Private biotech funding rounds by funding type. While both series A and series B rounds were the most popular funding types last month, with seven rounds of each taking place, it was series B rounds ...

Top biotech M&As of May 2025. In April, the major pharma giants in the mergers and acquisitions (M&As) space were Novartis and Merck. Last month, however, the big names that announced ...